Pseudomonas aeruginosa infection causes significant morbidity in vulnerable hosts. The nonredundant transposon insertion mutant library of P. aeruginosa strain PA14, designated as PA14NR Set, facilitates analysis of gene functionality in numerous processes. Presented here is a protocol to generate high-quality copies of the PA14NR Set mutant library.
Pseudomonas aeruginosa is a phenotypically and genotypically diverse and adaptable Gram-negative bacterium ubiquitous in human environments. P. aeruginosa is able to form biofilms, develop antibiotic resistance, produce virulence factors, and rapidly evolve in the course of a chronic infection. Thus P. aeruginosa can cause both acute and chronic, difficult to treat infections, resulting in significant morbidity in certain patient populations. P. aeruginosa strain PA14 is a human clinical isolate with a conserved genome structure that infects a variety of mammalian and nonvertebrate hosts making PA14 an attractive strain for studying this pathogen. In 2006, a nonredundant transposon insertion mutant library containing 5,459 mutants corresponding to 4,596 predicted PA14 genes was generated. Since then, distribution of the PA14 library has allowed the research community to better understand the function of individual genes and complex pathways of P. aeruginosa. Maintenance of library integrity through the replication process requires proper handling and precise techniques. To that end, this manuscript presents protocols that describe in detail the steps involved in library replication, library quality control and proper storage of individual mutants.
Pseudomonas aeruginosa is a phenotypically and genotypically diverse and adaptable Gram-negative bacterium present in soil, water, and most human environments, as well as skin microflora. Compared to many bacterial species, P. aeruginosa has a relatively large genome of 5.5-7 Mbp with high G+C content (65-67%). Furthermore, a significant proportion of its genes are involved in metabolic adaptability and are part of regulatory networks, allowing for great flexibility in response to environmental stress1. P. aeruginosa expresses a plethora of virulence factors, exhibits proclivity to form biofilms, possesses the ability to coordinate responses through multiple quorum sensing pathways, and displays a notable capacity to develop antibiotic resistance and tolerance2,3,4,5,6,7,8. These attributes present significant challenges for treating infections caused by P. aeruginosa.
Chronic P. aeruginosa infections can occur in numerous disease states. Cystic fibrosis (CF), a genetic disease caused by mutation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, results in inspissated, infected secretions within the airway, progressive bronchiectasis and, ultimately, death from respiratory failure9. By adulthood, the majority of patients with CF are chronically infected with P. aeruginosa, which plays a key role in the morbidity and mortality associated with this disease10. Additionally, patients with severe burn injuries11, tracheostomies12, joint replacements13, or indwelling catheters14 are at risk for P. aeruginosa infection related to the bacteria's ability to form biofilms and escape host inflammatory responses15. Further, colonization occurs without competition after a multi-antibiotic resistant or tolerant population is selected through broad-spectrum, sequential antimicrobial treatment12,16,17,18. Better understanding the pathogenesis of P. aeruginosa will have significant implications for numerous disease states.
Several P. aeruginosa clinical isolates, including strains PAO1, PA103, PA14 and PAK, have been extensively studied to investigate different features of P. aeruginosa pathogenesis. Strain PA14 is a clinical isolate that belongs to one of the most common clonal groups worldwide19,20 and has not been extensively passaged in the laboratory. PA14is highly virulent in vertebrate models of infection, with a notable endotoxin profile21, pili structure22, pathogenicity islands23, type III secretion system (TTSS), cytotoxicity towards mammalian cells24 and profiles in antibiotic resistance and persistence25. Furthermore, PA14 is also highly virulent in numerous host-pathogen model systems, including plant leaf infiltration models26,27,Caenorhabditis elegans infection models28,29, insect models30,31, as well as mouse pneumonia models32,33 and skin burn models34.
Genome-wide mutant libraries are collections of isogenic mutants in nonessential genes that constitute very powerful tools to understand the biology of an organism by allowing analysis of gene function on a genomic scale. Two near-saturation transposon insertion mutant libraries constructed in P. aeruginosa are currently available for distribution. The insertion sites of the transposons have been determined for both libraries. These so-called nonredundant libraries facilitate genome-wide studies of bacterial strains by considerably decreasing the time and cost involved in screening uncharacterized random transposon mutants. The P. aeruginosa PAO1 transposon mutant library, constructed in the MPAO1 isolate of strain PAO1 using transposons ISphoA/hah and ISlacZ/hah35, is curated by the Manoil lab, University of Washington. The library consists of a sequence-verified collection of 9,437 transposon mutants that provides wide genome coverage and includes two mutants for most genes36. Information about the P. aeruginosa PAO1 transposon mutant library is available at the public, internet-accessible Manoil lab website at http://www.gs.washington.edu/labs/manoil/libraryindex.htm. The P. aeruginosa strain PA14 nonredundant transposon insertion mutant library (PA14NR Set) constructed in strain PA14 using transposons MAR2xT7 and TnphoA37 is currently distributed by the Department of Pediatrics at Massachusetts General Hospital. The PA14NR Set comprises a collection of more than 5,800 mutants with single transposon insertions in nonessential genes37. Details on the construction of the PA14NR Set are described in the public, internet-accessible site http://pa14.mgh.harvard.edu/cgi-bin/pa14/home.cgi?section=NR_LIB, which also contains a variety of online search tools to facilitate the use of the PA14NR Set.
The original PA14NR Set comprised 5,459 mutants, selected from a comprehensive library of approximately 34,000 random transposon insertion mutants, that correspond to 4,596 predicted PA14 genes representing 77% of all predicted PA14 genes37. Since the construction of the library in 2006 new mutants were added, and presently the PA14NR Set includes more than 5,800 mutants38 that represent approximately 4,600 PA14 genes. The majority of the PA14 transposon mutants were generated in the wild type background37. Details concerning each member of the mutant library, including genetic background, are available either through searching the online database, or by downloading the Nonredundant Library spreadsheet, both features available on the PA14 website (http://pa14.mgh.harvard.edu/cgi-bin/pa14/home.cgi). The majority of mutants were created using the MAR2xT7 (MrT7) transposon, with a small set created using the TnPhoA (phoA) transposon37. Each transposon has an antibiotic resistance cassette, which allows for mutant selection using gentamicin (MrT7) or kanamycin (phoA). The PA14NR set of mutants is stored in sixty-three 96-well plates and includes two additional 96-well control plates, which consist of wild type PA14 inoculated and uninoculated wells intercalated in a preset pattern. The 96-well plate format paired with the online search tools greatly facilitates the custom development of screening assays that allow users to easily identify genes associated with mutant phenotypes. The online search tools also facilitate the search and selection of additional relevant mutants required for further studies.
The PA14 and PAO1 transposon mutant libraries are very important global resources for the scientific community, and they complement each other in validating the function of unknown genes and pathways of this bacterial pathogen. Coincidentally, since the construction of the PAO1 and PA14 transposon mutation libraries, full-genome DNA sequencing analysis of many P. aeruginosa isolates has shown that PAO1 and PA14 belong to different major subclades of the P. aeruginosa phylogeny7,39,40,41. Because clinical P. aeruginosa isolates are found distributed throughout the phylogeny, the fact that PAO1 and PA14 belong to different P. aeruginosa subgroups enhances the value of the two transposon mutation libraries for comparative studies.
Publications describing the construction and screening of bacterial mutant libraries, including P. aeruginosa libraries35,37,42, are readily available in the literature. However, to the best of our knowledge, no published protocols describing detailed procedures and techniques used for replication, maintenance, and validation of bacterial mutant libraries are available.
The methodology outlined in this publication describes a set of three protocols that facilitate the use and maintenance of the PA14NR Set. The first protocol describes replication of the library as recommended to recipients of the PA14NR Set. The second protocol includes guidelines for streaking, growing, and storing individual mutants identified using the PA14NR Set. The third protocol describes quality control techniques, including PCR amplification of fragments from transposon mutants and subsequent sequencing to confirm mutant identity. This set of protocols may also be adapted for the replication and maintenance of other bacterial mutant libraries or collections. The replication of bacterial mutant libraries or collections is highly advised to preserve the integrity of the "master copy" (original copy received). Replication of several copies of the PA14NR Set for routine laboratory use minimizes the probability of interwell contamination of the master copy.
CAUTION: Utilize standard BSL-2 safety measures when handling P. aeruginosa, a human pathogen. If you are an immunocompromised individual or have any medical condition that increases your susceptibility to bacterial infection, take special caution when working with P. aeruginosa. Consult the biosafety office in your institution and obtain approval from your physician before working with the the PA14 NR Set or mutant libraries of bacterial pathogens.
Figure 1: Overview of Protocol I: replication of the PA14NR set. Day 1: Replicate frozen mutant cultures from "master copy" of PA14NR Set into LB Agar media and grow mutants overnight at 37 °C. Day 2: Transfer mutant growth from LB Agar media to Deep Well Blocks containing LB liquid broth, grow overnight at 37 °C with shaking at 950 rpm. Day 3: Mix overnight LB cultures with glycerol, then transfer to 96-well destination plates for long-term storage. Place 96-well plates flat in -80 °C freezer. Please click here to view a larger version of this figure.
Figure 2: Recommended setup. Sterility and smooth workflow should be maintained through the use of appropriate precautions. Please click here to view a larger version of this figure.
1. Protocol I: Replication of the PA14NR Set
NOTE: Replication of the library can be achieved by dividing the PA14NR Set in four subsets of sixteen plates each that can be processed in four consecutive weeks. Generation of 1 to 6 copies adheres to the weekly workflow outlined in Table 1, while generation of more than 6 copies follows the weekly workflow outlined in Table 2. To generate 12 copies of the PA14NR Set, inoculate the same PA14NR subset into liquid LB media on Day 2 and again on Day 3 (from the same set of agar plates replicated on Day 1), and transfer overnight mutant cultures into copy plates on Day 3 and Day 4 respectively.
Day 0 | Day 1 | Day 2 | Day 3 |
Prep Day | Growth of PA14NR Set mutants on LB agar media | Growth of PA14NR Set mutants in liquid LB media | Transfer of PA14NR Set mutant cultures to destination plates |
Table 1: Schedule for replication of 1 – 6 copies of the PA14NR Set. Replication of a small number of copies may adhere to a weekly workflow.
Day 0 | Day 1 | Day 2 | Day 3 | Day 4 |
Prep Day | Growth of PA14NR Set mutants on LB agar | Grow of PA14NR Set mutants in liquid LB media | Transfer of Day 3 mutant cultures to generate 1st set of 6 copies of PA14NR Set | Transfer of Day 4 mutant cultures to generate 2nd set of 6 copies of PA14NR Set |
Growth of PA14NR Set mutants in liquid LB media |
Table 2: Schedule for replication of up to 12 copies of the PA14NR Set. Replication of a larger number of copies will require layering within a weekly workflow.
2. Protocol II: Handling and Storage of Individual Mutants from the PA14NR Set
3. Protocol III: Quality Control of PA14NR Set
Figure 3: PCR amplification and sequencing of transposon insertion mutants. Schematic view of steps involved in PCR amplification and sequencing for verification of mutant identity. Please click here to view a larger version of this figure.
PCR Reaction Set-up | |
Step 1 | Step 2 |
PCR1 reaction: | PCR2 reaction: |
23.25 µL water (Molecular Biology grade) | 19.15 µL Water (Molecular Biology Grade) |
3µL 10x Taq polymerase Buffer | 5 µL 10x Taq Polymerase Buffer |
0.5µL Taq polymerase | 0.6 µL Taq Polymerase |
0.625 µL 20 µM Primer Arb1D (Table 4) | 0.625 µL 20 µM Primer Arb2A (Table 4) |
0.625 µL 20 µM Transposon-specific Primer (PMFLGM.GB 3a or Tn5Ext ) (Table 4) | 0.625 mL 20 µM Transposon-specific Primer (PMFLGM.GB 2a or Tn5Int2) (Table 4) |
1 µL 10 mM dNTPs | 1 µL 10 mM dNTPs |
1 µL genomic DNA, 100 ng | 5 µL PCR1 reaction |
30 µL Final reaction volume | 30 µL Final reaction volume |
PCR Reaction Settings | |
PCR1 Thermocycler Conditions: | PCR2 Thermocycler Conditions: |
95 °C – 2 min | 95 °C – 2 min |
Repeat 5 cycles: | Repeat 30 cycles: |
95 °C – 30 s | 95 °C – 30 s |
30 °C – 1 min | 54 °C – 30 s |
72 °C – 1 min | 72 °C – 1.5 min |
Repeat 30 cycles: | 72 °C – 10 min |
95 °C – 30 s | 4 °C – Hold |
45 °C – 30 s | |
72 °C – 1 min | |
72 °C – 10 min | |
4°C – Hold |
Table 3: PCR reaction set-up and thermocycler conditions used for Arbitrary PCR. Arbitrary PCR reactions are performed sequentially, and fragments generated during PCR1 reaction are used as template in PCR2 reaction. Specific thermocycler settings are used for each set of reactions.
Primer Name | Primer Sequence |
MAR2xT7 Transposon-specific Primers | |
PMFLGM.GB-3a | TACAGTTTACGAACCGAACAGGC |
PMFLGM.GB-2a | TGTCAACTGGGTTCGTGCCTTCATCCG |
MAR2xT7 Transposon Sequencing Primer | |
PMFLGM.GB-4a | GACCGAGATAGGGTTGAGTG |
TnphoA Transposon-specific Primers | |
Tn5Ext | GAACGTTACCATGTTAGGAGGTC |
Tn5Int2 | GGAGGTCACATGGAAGTCAGATCCTGG |
TnphoA Transposon Sequencing Primer | |
Tn5Int | CGGGAAAGGTTCCGTTCAGGACGC |
Arbitrary Primers | |
ARB1D | GGCCAGGCCTGCAGATGATGNNNNNNNNNNGTAT |
ARB2A | GGCCAGGCCTGCAGATGATG |
Table 4: List of Primers used in Quality Control Experiments. Primers used for PCR amplification and sequencing of transposon insertion mutants to confirm mutant identity.
Twelve new copies of the PA14NR Set were replicated using Protocol I, and a quality control assessment of the new copies generated was conducted using Protocol III.
PA14NR Set mutant plates along with Control Plates, which consist of wild type PA14 inoculated and uninoculated wells intercalated in a preset pattern (Figure 4A), were replicated following methology described in Protocol I. Control plates are included in the PA14NR Set to evaluate possible interwell contamination when performing plate replication. Additionally, control plates can be used to practice replication techniques prior to accessing plates containing transposon insertion mutants. Growth of control plates was visually inspected after replication on LB agar plates and overnight incubation to ensure the presence of expected growth patterns (Figure 4B). Presence or absence of bacterial growth in deep well blocks inoculated with Control Plate 1 was assessed after overnight incubation by reading OD600 in spectrophotometer. Results showed substantial growth in the wild type PA14 inoculated wells and complete absence of growth in the uninoculated wells (Figure 4C). Although there was some variability in the growth of wild type PA14 cultures, there was complete absence of growth in the uninoculated wells (Figure 4D).
Thirty-eight mutant strains randomly selected from one of the newly generated copies of the PA14NR Set were analyzed by sequencing DNA fragments generated by arbitrary PCR. Arbitrary PCR reactions were carried out to amplify DNA fragments from regions surrounding transposon insertions of the 38 mutants selected, and the PCR fragments obtained were subsequently sequenced. An example of PCR fragments obtained after PCR amplification of nine distinct transposon insertion mutants is shown in Figure 5. As annealing of arbitrary primers occurs at random, fragment length cannot be predicted. When no bands were visible, PCR reactions were repeated. The identity of the transposon insertions contained in the 38 mutants analyzed was found using the PA14 Transposon Insertion Mutant Library link (http://pa14.mgh.harvard.edu/cgi-bin/pa14/search.cgi) to select the primers necessary to perform arbitrary PCR reactions.
Sequencing results obtained from the 38 mutant strains were BLASTed against the complete genome of strain PA14 using the blast link provided on the PA14NR Library website (http://pa14.mgh.harvard.edu/cgi-bin/pa14/blast.cgi). Sequencing results from randomly selected mutants were also aligned against the gene sequences that corresponded to each individual mutant (obtained using the PA14NR Set plate position search tool found on the PA14NR Library website http://pa14.mgh.harvard.edu/cgi-bin/pa14/search.cgi?searchType=SEARCH_PLATE_POSITIONS). Sequence alignments were performed using the Align Sequences Nucleotide BLAST tool provided by NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=MegaBlast&PROGRAM=blastn&BLAST_PROGRAMS=megaBlast&PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2seq&DATABASE=n/a&QUERY=&SUBJECTS=).
Two of the 38 mutants selected generated low quality sequence results, probably due to high GC content in the region containing the transposon insertion, and could not be analyzed further. Sequence results from 35 of the 36 succesfully sequenced mutants matched the sequences of the genes corresponding to the PA14NR Set selected mutants. Only one out of the 36 sequences failed to match the sequence of the gene that corresponds to the mutant selected. However, it was not established if this discrepancy resulted from a problem that occurred during replication of the new copies of the PA14NR Set or could be attributed to the 2.8% mislabeling error estimated earlier for the PA14NR Set37.
Figure 4: PA14NR set control plates. A) Layout of PA14NR Set Control Plates 1 and 2. B) Picture of PA14 NR Set Control Plates 1 and 2 replicated on LB Agar (view from top of agar plate). C) Average bacterial growth (+/-SD) measured in inoculated and uninoculated wells of Control Plate 1 after overnight incubation in Deep Well Block. Readings were performed at OD600. D) Bacterial growth measured in inoculated and uninoculated wells of Control Plate 1 after overnight incubation in Deep Well Block. Readings were performed at OD600 in individual wells. Even columns correspond to measurements performed in uninoculated wells; odd columns correspond to measurements performed in PA14-inoculated wells. Please click here to view a larger version of this figure.
Figure 5: PCR1 and PCR2 fragments obtained from amplification reactions. Example of fragments obtained using Arbitrary PCR amplification reactions. Fragments in lanes 1 – 9 correspond to different mutants selected at random to perform quality controls of PA14NR Set replicated plates. MWM: DNA Molecular weight marker. DNA MWM sizes are in base pairs.
PA14NR Set mutant strains tested: Lane 1: 07_4 A10, lane 2: 07_4 B4, lane 3: 08_1 C3, lane 4: 08_1 H6, lane 5: 08_3 G10, lane 6: 08_4 B8, lane 7: 08_4 H3, lane 8: 09_2 D12, lane 9: 09_2 G5. Please click here to view a larger version of this figure.
The P. aeruginosa PA14NR Set is a valuable resource for the scientific community. According to the March 2017 dataset from Clarivate Analytics' Essential Science Indicators database, Liberati et al. (2006)37, which describes the construction of the PA14NR Set, is ranked in the top 1% of microbiology publications. Google Scholar reports over 600 citations of the Liberati et al. (2006) original manuscript as of August 2017. The library has played an important role in elucidating the mechanisms underlying P. aeruginosa pathogenesis. Importantly, the 96-well plate format of the PA14NR Set facilitates high throughput genetic screens designed to study a variety of P. aeruginosa mutant phenotypes44,45,46. As the PA14NR Set is available for distribution, special precautions must be used to preserve the integrity of this resource.
A number of publications demonstrate the utility of using the PA14NR Set in genetic screens37,38,47,48. For example, as an initial test of the utility of the library, Liberati et al. performed a PVC (polyvinyl chloride) attachment screen, which correlates with the bacteria's ability to form biofilms37,38,47,48. The library's format also allows the study of complex genetic traits such as swarming motility, evidenced by the identification of hundreds of genes of interest in a simple screen48. The PA14NR Set was used also in a large-scale MALDI-TOF mass spectrometry-based screen to acquire and analyze intact-cell proteome profile spectra and assess the effectiveness of MALDI-TOF Biotyping47. Applying this technique, researchers were able to determine whether minor genomic differences, such as those that result from transposon insertions, are disruptive to biotyping efforts which are used in clinical and therapeutic environments. Additionally, the PA14NR Set was used to perform a genome-wide screen for attenuation of PA14 virulence in a C. elegans infection model, allowing the identification of previously uncharacterized P. aeruginosa virulence-related genes38, and thereby providing an example of the use of the PA14 library to study host-pathogen interactions.
The PA14NR Set also serves as an important resource for the study of individual mutants. To avoid contamination of the library, best practices for accessing mutants of interest are recommended. Because handling of the library increases the possibility of contamination, it is recommended to store mutants of interest in individual vials to limit access to the PA14NR Set working and master copies. This prevents contamination, improves the longevity of the library, and protects the investment.
In order to preserve the integrity of the important PA14NR Set resource, it is advised that all recipients of the PA14NR Set make copies of the library upon receipt. Despite best efforts, the potential for inadvertent contamination during replication procedures cannot be excluded. Therefore, it is strongly recommended that users complete quality control checks after library replication and after using the library to perform genetic screens. It is also strongly recommended that users make additional copies of the PA14NR Set to perform genetic screens as the probability of interwell contamination increases. In addition, library copies used to perform more than 2-3 genetic screens should be subjected to exhaustive quality control assessments. Unfortunately, there is no proper way to recover libraries that experience loss of clones or interwell contamination. Compromised or contaminated copies must be discarded. As a consequence, it is recommended that users replicate several copies of the library for routine laboratory use, considering that a copy's useful life is limited. Also it is recommended that users limit access to the "master copy" to preserve the integrity of the PA14NR Set.
The protocols presented here provide a detailed explanation of the replication techniques, including set-up, protocols, and best practices. The replication protocols described for the PA14NR Set can be adapted to generate up to 12 copies of the library and can also be readily adapted to replicate other bacterial mutant libraries. To the best of our knowledge, there are no published protocols available to date with detailed descriptions of the procedures and techniques used for replication, maintenance and validation of bacterial mutant libraries. We hope these protocols will provide users of the PA14NR Set and other bacterial mutant libraries with the information necessary to perform these important tasks.
Whether the library is used for high throughput screens or as a source for individual mutants, it is important to periodically assess the integrity of the copy in use. To do this, adequate training of personnel and re-assessing replication or mutant selection techniques should be done periodically. The use of PA14NR Set control plates and performance of routine PCR amplification and sequencing of random mutants to confirm their identity is highly recommended. Liberati el al. (2006)37 estimated that 2.8% of the total number of mutants in the PA14NR Set was mislabeled, which highlights the need to sequence specific transposon mutants and to generate in-frame deletion mutants before starting any comprehensive study and/or publication of research involving specific genes. Given proper protocols and methods for library replication and selection of individual mutants for further study, the PA14NR Set will contribute to the understanding of P. aeruginosa pathogenicity and the improvement of clinical outcomes for infected patients.
The authors have nothing to disclose.
We would like to thank Lisa Philpotts of the MGH Treadwell Virtual Library for her guidance in the database search. This work was supported by the Cystic Fibrosis Foundation (YONKER16G0 and HURLEY16G0) and NIH NIAID (BPH and ADE: R01 A1095338).
Materials for Library Replication | |||
Sterile 96-well Tissue-culture treated, case of 50 | Corning Life Sciences | 353072 | via Fisher Scientific |
Sterile 96 Well Clear V-Bottom 2000μL Deep Well Plates, case of 25 | Corning Life Sciences | 3960 | via Fisher Scientific |
Nunc OmniTray (rectangular plates), case of 60 | Thermo Scientific Rochester | 242811 | via Fisher Scientific |
Rectangular Ice Pan, Midi (4L) | Corning Life Sciences | 432104 | via Fisher Scientific |
Secure-Gard Cone Mask, case of 300 | Cardinal Health | AT7509 | via Fisher Scientific |
AluminaSeal, pack of 100 | Diversified Biotech | ALUM-100 | via Fisher Scientific |
Breathe-Easy membrane, pack of 100 | Diversified Biotech | BEM-1 | via Sigma-Aldrich |
Sterile, individually wrapped, 50mL Solution Trough/Reagent Reservoir, case of 100 | Sorenson | S50100 | via Westnet Incorporated |
Plate roller | VWR | 60941-118 | via VWR |
Cryo Laser Labels – CRYOLAZRTAG 2.64" x 0.277", pack of 16 sheets | GA International | RCL-11T1-WH | via Labtag.com (template for printing also available from Labtag.com) |
96-well replicator | V & P Scientific, Inc. | Custom 407C, 3.18mm pin diameter, 57mm long | via V & P Scientific, Inc. |
Multitron Pro, 3mm Shaking incubator | Infors HT | l10003P | via Infors HT |
Picus 12 Channel 50-1200μL Electronic Pipette | Sartorius | 735491PR | via Sartorius |
Filter Tips 50-1200μL, pack of 960 | Biohit | 14-559-512 | via Fisher Scientific; use electronic multichannel-compatible tips |
Dry Ice | User-specific vendor | ||
Materials for Individual Mutant Storage | |||
Fisherbrand Premium Microcentrifuge Tubes: 1.5mL | Fisher Scientific | 05-408-130 | via Fisher Scientific |
Pipettes (P1000, P200, P20, P2) | Gilson | F167370 | via Gilson |
Materials for Quality Control PCR | |||
Fisherbrand Premium Microcentrifuge Tubes: 1.5mL | Fisher Scientific | 05-408-130 | via Fisher Scientific |
NanoDrop | Thermo Scientific | ND-2000 | via ThermoFisher |
PCR Thermocycler | |||
Omnistrips PCR Tubes with domed lids | Thermo Scientific | AB0404 | via Fisher Scientific |
ART Barrier low-retention pipette tips (10 uL, 100 uL, 1000 uL) | Molecular BioProducts, Inc. | Z676543 (10 uL), Z676713 (100 uL), Z676802 (1000 uL) | via Sigma-Aldrich |
Pipettes (P1000, P200, P20, P2) | Gilson | F167370 | via Gilson |
Fisherbrand Premium Microcentrifuge Tubes: 1.5mL | Fisher Scientific | 05-408-130 | via Fisher Scientific |
MasterPure DNA Purification Kit | Epicentre | MCD85201 | via Epicentre Technologies Corp |
GeneRuler 1 kb Plus DNA Ladder, ready-to-use | Thermo Scientific | SM1333 | via ThermoFisher |
RediLoad Loading Buffer | Invitrogen | 750026 | via ThermoFisher |
Chemicals | |||
Chemicals for Library and Individual Mutant Storage | |||
Glycerol MB Grade, 1L | Sigma Aldrich | G5516 | via Sigma-Aldrich |
LB Broth | Per 1L dH2O: 10g tryptone, 5g yeast extract, 5g NaCl, 1ml 1N NaOH (Current Protocols in Molecular Biology. Wiley, 1994.) | ||
Tryptone | Sigma Aldrich | T7293 | via Sigma-Aldrich |
Yeast Extract | Sigma Aldrich | Y1625 | via Sigma-Aldrich |
Sodium Chloride | Sigma Aldrich | S7653 | via Sigma-Aldrich |
Sodium Hydroxide | Sigma Aldrich | S8045 | via Sigma-Aldrich |
LB agar | See preparation above, add 15g Bacto Agar | ||
Bacto Agar | Sigma Aldrich | A5306 | via Sigma-Aldrich |
Gentamicin sulfate, 10g | BioReagent | 1405-41-0 | via Sigma-Aldrich |
Kanamycin sulfate | Gibco | 11815024 | via ThermoFisher |
Ethanol, 190 proof | Decon | 04-355-221 | via Fisher Scientific |
Chemicals for Quality Control PCR | |||
Primers | User-preferred vendor | See primers listed in Table 3 | |
Corning cellgro Molecular Biology Grade Water | Corning | 46000CV | via Fisher Scientific |
Taq Polymerase Buffer | Invitrogen | 10342020 | via ThermoFisher |
Taq DNA Polymerase, recombinant | Invitrogen | 10342020 | via ThermoFisher |
dNTPs | Invitrogen | 10297018 | via ThermoFisher |
Agarose | Sigma | A9539 | via Sigma-Aldrich |